- Home
- OMCL vs PGEN Comparison
OMCL vs PGEN Comparison
Compare OMCL & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OMCL | PGEN |
|---|---|---|
| Founded | 1992 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2000 | 2013 |
Fundamental Metrics
Financial Performance| Metric | OMCL | PGEN |
|---|---|---|
| Price | $40.71 | $4.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $51.14 | $7.67 |
| AVG Volume (30 Days) | 797.6K | ★ 3.9M |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 160.00 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $787,309,000.00 | $230,981,000.00 |
| Revenue This Year | $6.77 | $342.78 |
| Revenue Next Year | $4.82 | $478.46 |
| P/E Ratio | $446.11 | ★ N/A |
| Revenue Growth | ★ 9.93 | N/A |
| 52 Week Low | $22.66 | $1.11 |
| 52 Week High | $51.84 | $5.47 |
Technical Indicators
Market Signals| Indicator | OMCL | PGEN |
|---|---|---|
| Relative Strength Index (RSI) | 46.43 | 40.70 |
| Support Level | $28.61 | $3.49 |
| Resistance Level | $46.29 | $5.16 |
| Average True Range (ATR) | 2.02 | 0.37 |
| MACD | 0.25 | -0.10 |
| Stochastic Oscillator | 90.13 | 5.25 |
Price Performance
Historical ComparisonAbout OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.